000 | 01937 a2200541 4500 | ||
---|---|---|---|
005 | 20250516192716.0 | ||
264 | 0 | _c20150713 | |
008 | 201507s 0 0 eng d | ||
022 | _a1520-7560 | ||
024 | 7 |
_a10.1002/dmrr.2529 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aAubert, C E | |
245 | 0 | 0 |
_aAssociation of peripheral neuropathy with circulating advanced glycation end products, soluble receptor for advanced glycation end products and other risk factors in patients with type 2 diabetes. _h[electronic resource] |
260 |
_bDiabetes/metabolism research and reviews _cNov 2014 |
||
300 |
_a679-85 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aArterial Occlusive Diseases _xcomplications |
650 | 0 | 4 | _aCross-Sectional Studies |
650 | 0 | 4 |
_aDiabetes Mellitus, Type 2 _xblood |
650 | 0 | 4 |
_aDiabetic Angiopathies _xcomplications |
650 | 0 | 4 |
_aDiabetic Neuropathies _xcomplications |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aGlycation End Products, Advanced _xblood |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aLysine _xanalogs & derivatives |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aParis _xepidemiology |
650 | 0 | 4 |
_aPeripheral Nervous System _xphysiopathology |
650 | 0 | 4 | _aPrevalence |
650 | 0 | 4 | _aReceptor for Advanced Glycation End Products |
650 | 0 | 4 |
_aReceptors, Immunologic _xblood |
650 | 0 | 4 | _aRisk Factors |
650 | 0 | 4 | _aSeverity of Illness Index |
650 | 0 | 4 | _aSex Factors |
650 | 0 | 4 | _aSolubility |
650 | 0 | 4 | _aWaist Circumference |
700 | 1 | _aMichel, P-L | |
700 | 1 | _aGillery, P | |
700 | 1 | _aJaisson, S | |
700 | 1 | _aFonfrede, M | |
700 | 1 | _aMorel, F | |
700 | 1 | _aHartemann, A | |
700 | 1 | _aBourron, O | |
773 | 0 |
_tDiabetes/metabolism research and reviews _gvol. 30 _gno. 8 _gp. 679-85 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1002/dmrr.2529 _zAvailable from publisher's website |
999 |
_c23471990 _d23471990 |